Heart in Diabetes (HiD)
Avatar

Clinical Interventions in Atherosclerosis

By Heart in Diabetes (HiD) FEATURING Robert Chilton
By Heart in Diabetes (HiD) FEATURING Robert Chilton
180 views
October 7, 2024
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
22:42
Heart in Diabetes (HiD)

Functional Hypothalamic Amenorrhea: Consequences Beyond the Menstrua…

Feat. C. Shufelt
18:39
Heart in Diabetes (HiD)

Cardiovascular Disease in the Very Old

Feat. C. Ballantyne
15:12
Penn Medicine Heart and Vascular Center

What Are the Metabolic Consequences of Insulin Resistance and What I…

Feat. D. Soffer
20:01
National Lipid Association

What’s New in Obesity Pharmacotherapy?

Feat. H. Bays
19:08
Heart in Diabetes (HiD)

New Targets and Upcoming Medications for Dyslipidemia

Feat. N. E. Lepor
14:04
Penn Medicine Heart and Vascular Center

Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?

Feat. A. Bajaj
12:55
The North American Thrombosis Forum (NATF)

Getting Your Cholesterol to Goal: The Growing List of Therapies

Feat. N. Marston
24:02
Heart in Diabetes (HiD)

Eradicating Atherosclerotic Events by Targeting Early Subclinical Di…

Feat. K. Jon Williams
18:53
Robert Dubin

Glucagon-like Peptide-1 Receptor Agonist-Based Agents and Weight Los…

21:01
Heart in Diabetes (HiD)

Heart Failure Post Myocardial Infraction and Valvular Disease

Feat. J. Butler
11:29
James O'Keefe

GLP’s Are Anti-Consumption and Longevity Agents and SGLT-i’s Slow Ag…

16:39
Heart in Diabetes (HiD)

Impact of Cumulative Risk Factor Exposure on Incident Cardiovascular…

Feat. M. J. Domanski
37:52
Keck School of Medicine of USC

Can I Ever Be Cured? Strategies for Remission of Type 2 Diabetes

Feat. R. Retnakaran
26:16
Integrative Medicine - Astrid Pujari

Should I Use a Continuous Glucose Monitor, Even if I'm Healthy?

Feat. A. Pujari
25:31
University Hospitals

CAC Scoring in Assessment of Cardiovascular Risk

Feat. G. Rao, I. Neeland
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

55:12
University of Louisville

Current Trends in Obesity Pharmacotherapy: Is the Wait (Weight) Over?

Feat. S. S. Krishnasamy
15:53
Heart in Diabetes (HiD)

Medical Treatment of Hypercortisolism With Relacorilant: Final Resul…

Feat. R. Pivonello
19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne